EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Phoenix Financial Ltd. Raises Stock Position in Bristol Myers Squibb Company $BMY
Vanguard Personalized Indexing Management LLC Reduces Stock Position in Bristol Myers Squibb Company $BMY
Mutual of America Capital Management LLC Lowers Position in Bristol Myers Squibb Company $BMY - Markets Daily
Syngene Presses Ahead With Capex And Capacity Build As Biologics Impact Weighs On Q3
Belpointe Asset Management LLC Purchases 30,833 Shares of Bristol Myers Squibb Company $BMY
Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockade
RET Fusion Targeted Therapies Market Set for Robust Growth by 2034 Amid Precision Oncology Shift | DelveInsight
Patten & Patten Inc. TN Decreases Stock Holdings in Bristol Myers Squibb Company $BMY - Markets Daily
Bristol Myers Squibb Company $BMY Shares Sold by Patten & Patten Inc. TN - Stock Observer
Lbp Am Sa Cuts Stake in Bristol Myers Squibb Company $BMY - Daily Political
MBM Wealth Consultants LLC Takes Position in Bristol Myers Squibb Company $BMY - Markets Daily
Bristol Myers Squibb Company $BMY Shares Acquired by Sector Gamma AS - Markets Daily
Trek Financial LLC Invests $1.49 Million in Bristol Myers Squibb Company $BMY - Markets Daily
Bristol Myers Squibb Company $BMY Shares Sold by Quilter Plc
Resona Asset Management Co. Ltd. Sells 46,004 Shares of Bristol Myers Squibb Company $BMY - Markets Daily
Resona Asset Management Co. Ltd. Lowers Stock Holdings in Bristol Myers Squibb Company $BMY
Bristol Myers Squibb Company $BMY Shares Purchased by UniSuper Management Pty Ltd
Bristol Myers Squibb Company $BMY Shares Acquired by Mitsubishi UFJ Trust & Banking Corp
iA Global Asset Management Inc. Boosts Stake in Bristol Myers Squibb Company $BMY
Strs Ohio Decreases Holdings in Bristol Myers Squibb Company $BMY
Camzyos Trial Win and Microsoft AI Lung Program Might Change The Case For Investing In BMY
A Look At Bristol Myers Squibb (BMY) Valuation After New Microsoft AI Pact And Camzyos Trial Results
Teacher Retirement System of Texas Increases Position in Bristol Myers Squibb Company $BMY - Markets Daily
Zydus Lifesciences launches world's first nivolumab biosimilar in India, boosting cancer treatment affordability - The Economic Times
Syngene Intl looks to diversify revenue as single biologics programme weighs on performance
Teacher Retirement System of Texas Acquires 168,780 Shares of Bristol Myers Squibb Company $BMY - Stock Observer
Did AI Lung Imaging And New HCM Data Just Shift Bristol Myers Squibb's (BMY) Investment Narrative?
Zydus Rolls Out Biosimilar of 'Nivolumab' Cancer Drug - The Economic Times
Microsoft Pushes Applied AI Deeper Into Retail And Healthcare Workflows
Want Decades of Passive Income? Buy This ETF and Hold It Forever
Q4 EPS Forecast for Bristol Myers Squibb Reduced by Analyst
Johnson & Johnson (NYSE:JNJ) Q4 2025 Earnings Call Transcript
Janux Therapeutics, Bristol Myers enter up to $850 million deal to develop cancer drug
Janux Enters Collaboration And Exclusive Worldwide License Agreement With Bristol Myers Squibb
Zydus launches Opdivo biosimilar in India at one-fourth price of reference brand
Assessing Bristol Myers Squibb (BMY) Valuation After New Microsoft Lung Cancer Detection Partnership
Janux's tumor-activated platform draws BMS in potential $850M deal | BioWorld
Bristol-Myers (BMY): UBS Turns Bullish as Biotech and Pharma Show Signs of a Recovery
Bristol Myers Squibb Announces Collaboration with Microsoft to Advance AI-Driven Early Detection of Lung Cancer
Telangana Targets $25 Billion Life Sciences Investment Push
Leerink Bullish on Bristol-Myers Squibb Company (BMY) Amid Ample Pipeline Optionality in 2026
Zacks Research Has Negative Outlook for BMY Q1 Earnings - Markets Daily
Microsoft (NASDAQ:MSFT) Price Target Cut to $660.00 by Analysts at Citigroup - Stock Observer
Bristol Myers Squibb Company (NYSE:BMY) Receives $56.86 Average Price Target from Analysts - Stock Observer
Bristol Myers Squibb (NYSE:BMY) Trading Down 1.9% - Here's Why
Bernstein Keeps Their Hold Rating on Bristol-Myers Squibb (BMY) | Markets Insider
Bristol Myers Squibb (NYSE:BMY) Shares Down 1.9% - Should You Sell? - Stock Observer
Bristol-Myers Squibb (BMY) Upgraded to Buy by UBS, Noting a Skewed Risk/Reward Ratio for the Stock
Drug pricing, patent losses, deals: Novo Nordisk, Pfizer execs weigh in
Bristol Myers partners with Microsoft for AI-driven lung cancer detection
Bristol Myers Squibb Foundation Launches National Program t
2 Top Blue-Chip Stocks to Buy and Hold in 2026 | Morningstar
Scotiabank Notes Bristol-Myers Squibb Company (BMY) as Appealing Investment in 2026
Allstate Corp Purchases New Holdings in Bristol Myers Squibb Company $BMY
Bristol Myers Squibb and Syngene Extend Strategic Partnership to 2035, ETPharma
Syngene - Bristol Myers Squibb collaboration extended to 2035
Bristol Myers Squibb (NYSE:BMY) Stock Unloaded Rep. Julie Johnson - Daily Political
Tred Avon Family Wealth LLC Takes Position in Bristol Myers Squibb Company $BMY
QRG Capital Management Inc. Sells 75,294 Shares of Bristol Myers Squibb Company $BMY
Bristol Myers Squibb Company $BMY Stock Holdings Lowered by Pinnacle Financial Partners Inc
Bristol Myers Squibb Company (NYSE:BMY) Given Average Recommendation of "Hold" by Brokerages
Bristol Myers Squibb Company $BMY Shares Sold by Concurrent Investment Advisors LLC
Campbell & CO Investment Adviser LLC Has $5.81 Million Stock Position in Bristol Myers Squibb Company $BMY
Procyon Advisors LLC Acquires 8,907 Shares of Bristol Myers Squibb Company $BMY - Stock Observer
The Bull Case For Bristol-Myers Squibb (BMY) Could Change Following Camzyos' Phase 3 Adolescent oHCM Win
Bristol Myers Squibb (NYSE:BMY) Price Target Raised to $60.00 - Stock Observer
Factbox-Major deals involving U.S. drugmakers and biotechs over the past decade
Stephens Inc. AR Raises Stock Position in Bristol Myers Squibb Company $BMY
Stephens Inc. AR Purchases 32,476 Shares of Bristol Myers Squibb Company $BMY - Stock Observer
Bristol Myers Squibb (NYSE:BMY) Trading 1.9% Higher After Analyst Upgrade
Rep. Gilbert Ray Cisneros, Jr. Buys Bristol Myers Squibb Company (NYSE:BMY) Shares
Bristol-Myers Squibb Reports Positive Phase 3 SCOUT-HCM Results for Camzyos in Adolescent Patients
Healthy Returns: Novo Nordisk CEO talks GLP-1 pill at JPMorgan conference
Manning & Napier Advisors LLC Lowers Stake in Bristol Myers Squibb Company $BMY
Cullinan Associates Inc. Trims Stock Holdings in Bristol Myers Squibb Company $BMY
Bristol Myers Squibb Company $BMY Shares Sold by Manning & Napier Advisors LLC - Daily Political
Unravelling co-mutational patterns with prognostic implications in NPM1 mutated adult acute myeloid leukemia - a HARMONY study
Is Bristol Myers Squibb (BMY) Pricing Reflect Long Term Cash Flow Prospects At US$55.92?
Leerink Partners Issues Positive Forecast for Bristol Myers Squibb (NYSE:BMY) Stock Price
Acute Myeloid Leukemia Market Analysis and Forecast, 2025-2035: Precision Medicine Leads Growth
10 Cheap S&P 500 Stocks to Invest in Now
Oramed and Lifeward Announce Strategic Transaction PR Newswi
Bristol Myers Squibb Company $BMY Shares Sold by GRIMES & Co WEALTH MANAGEMENT LLC
Relief For Cancer Patients As Delhi HC Allows Sale Of 70% Cheaper Nivolumab Biosimilar | India News - News18
Cheaper Cancer Drugs vs Patents: Will Delhi HC's Zydus Ruling Expand Access To Treatment? | Explainers News - News18
Bristol Myers Squibb Company $BMY Position Raised by Sumitomo Mitsui Trust Group Inc. - Daily Political
Linavonkibart and pembrolizumab in immune checkpoint blockade-resistant advanced solid tumors: a phase 1 trial
HC Allows Zydus to Sell Cancer Biosimilar Drug - The Economic Times
Delhi HC clears Zydus biosimilar, boosting access to affordable cancer care | India News - The Times of India
Scotiabank Raises Bristol-Myers (BMY) PT to $60 Citing Catalyst-Rich 2026 Growth
SAN FRANCISCO-Bristol Myers…
Critical Review: Bristol Myers Squibb (NYSE:BMY) & VivoSim Labs (NASDAQ:VIVS) - Markets Daily
First Horizon Corp Acquires New Holdings in Bristol Myers Squibb Company $BMY
Head to Head Comparison: VivoSim Labs (NASDAQ:VIVS) & Bristol Myers Squibb (NYSE:BMY) - Stock Observer
Delhi HC clears Zydus to sell biosimilar of BMS cancer drug Nivolumab - The Economic Times
BristolMyers News
TTD stock is trading down 7% today: What’s happening with Trade Desk Inc?
Nvidia invests $2 billion in CoreWeave: Will CRWV stock skyrocket in 2026?
Gold price forecast: XAU/USD rises to record high near $5,050, what’s next?
